Outset Medical (OM) Short-term Investments (2019 - 2026)
Outset Medical has reported Short-term Investments over the past 7 years, most recently at $133.9 million for Q4 2025.
- Quarterly Short-term Investments rose 286.32% to $133.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $133.9 million through Dec 2025, up 286.32% year-over-year, with the annual reading at $133.9 million for FY2025, 286.32% up from the prior year.
- Short-term Investments was $133.9 million for Q4 2025 at Outset Medical, down from $142.2 million in the prior quarter.
- Over five years, Short-term Investments peaked at $214.3 million in Q4 2022 and troughed at $25.7 million in Q1 2021.
- The 5-year median for Short-term Investments is $150.8 million (2024), against an average of $147.7 million.
- Year-over-year, Short-term Investments skyrocketed 689.73% in 2021 and then crashed 74.28% in 2024.
- A 5-year view of Short-term Investments shows it stood at $157.1 million in 2021, then soared by 36.36% to $214.3 million in 2022, then crashed by 37.08% to $134.8 million in 2023, then crashed by 74.28% to $34.7 million in 2024, then skyrocketed by 286.32% to $133.9 million in 2025.
- Per Business Quant, the three most recent readings for OM's Short-term Investments are $133.9 million (Q4 2025), $142.2 million (Q3 2025), and $144.5 million (Q2 2025).